CII
ELV icon

CR Intrinsic Investors’s Elevance Health ELV Stock Holding History

CR Intrinsic Investors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-325,000
Closed -$27.2M – 293
2013
Q3 		$27.2M Buy
+325,000
New +$27.9M 0.84% 20

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

CR Intrinsic Investors's ELV Position: Q4 2013 in Review

CR Intrinsic Investors sold out of Elevance Health (ELV) in Q4 2013, closing a stake of 325,000 shares — an estimated $27.2M sold.

CR Intrinsic Investors first reported a position in ELV in Q3 2013 and held it in 1 quarter. The position peaked at $27.2M in Q3 2013. 639 funds tracked by Wall St. Rank hold ELV as of Q4 2013.

  • CR Intrinsic Investors reported no remaining Elevance Health position as of Q4 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 325,000 Elevance Health shares in Q4 2013, an estimated $27.2M.
  • CR Intrinsic Investors first reported a position in Elevance Health in Q3 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's Elevance Health position peaked at $27.2M in Q3 2013.
  • 639 funds tracked by Wall St. Rank held Elevance Health as of Q4 2013.

Based on CR Intrinsic Investors's 13F filing for Q4 2013, filed 14 Feb 2014.